Unlabelled: Oropouche virus (OROV) is a midge-borne human pathogen with a geographic distribution in South America. OROV was first isolated in 1955, and since then, it has been known to cause recurring outbreaks of a dengue-like illness in the Amazonian regions of Brazil. OROV, however, remains one of the most poorly understood emerging viral zoonoses. Here we describe the successful recovery of infectious OROV entirely from cDNA copies of its genome and generation of OROV mutant viruses lacking either the NSm or the NSs coding region. Characterization of the recombinant viruses carried out in vitro demonstrated that the NSs protein of OROV is an interferon (IFN) antagonist as in other NSs-encoding bunyaviruses. Additionally, we demonstrate the importance of the nine C-terminal amino acids of OROV NSs in IFN antagonistic activity. OROV was also found to be sensitive to IFN-α when cells were pretreated; however, the virus was still capable of replicating at doses as high as 10,000 U/ml of IFN-α, in contrast to the family prototype BUNV. We found that OROV lacking the NSm protein displayed characteristics similar to those of the wild-type virus, suggesting that the NSm protein is dispensable for virus replication in the mammalian and mosquito cell lines that were tested.

Importance: Oropouche virus (OROV) is a public health threat in Central and South America, where it causes periodic outbreaks of dengue-like illness. In Brazil, OROV is the second most frequent cause of arboviral febrile illness after dengue virus, and with the current rates of urban expansion, more cases of this emerging viral zoonosis could occur. To better understand the molecular biology of OROV, we have successfully rescued the virus along with mutants. We have established that the C terminus of the NSs protein is important in interferon antagonism and that the NSm protein is dispensable for virus replication in cell culture. The tools described in this paper are important in terms of understanding this important yet neglected human pathogen.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810690PMC
http://dx.doi.org/10.1128/JVI.02849-15DOI Listing

Publication Analysis

Top Keywords

orov
12
nsm protein
12
viruses lacking
8
nsm nss
8
virus
8
oropouche virus
8
virus orov
8
human pathogen
8
south america
8
outbreaks dengue-like
8

Similar Publications

Oropouche fever is an increasingly significant health concern in tropical and subtropical areas of South and Central America, and is primarily spread by midge vectors. The Oropouche virus (OROV) was first identified in 1955 and has been responsible for numerous outbreaks, particularly in urban environments. Despite its prevalence, the disease is often under-reported, making it difficult to fully understand its impact.

View Article and Find Full Text PDF

Efficient Expression of Oropouche Virus Nonstructural Proteins NSs and NSm.

Methods Mol Biol

December 2024

Department of Pathology, The Sealy Institute for Vaccine Sciences, The Center for Biodefense and Emerging Infectious Diseases, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.

Oropouche fever, a mosquito- or midge-borne emerging zoonotic disease endemic to South and Central America, manifests as a dengue-like acute febrile illness with occasional occurrences of meningitis or meningoencephalitis. The causative agent, Oropouche virus (OROV), belongs to the genus Orthobunyavirus within the family Peribunyaviridae. Its tripartite negative-sense RNA genome comprises small (S), medium (M), and large (L) segments, encoding structural N, Gn/Gc, and L proteins, respectively.

View Article and Find Full Text PDF

Oropouche virus: Understanding "sloth fever" disease dynamics and novel intervention strategies against this emerging neglected tropical disease.

Virulence

December 2024

Department of Veterinary & Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, Twin Cities, MN, USA.

Article Synopsis
  • Oropouche virus (OROV) is an arbovirus that causes "sloth fever," transmitted mainly by midges in both rural and urban areas.
  • Human infections can result in acute fever and, in severe cases, neurological issues, with over half a million people infected since its first detection in 1955.
  • The absence of FDA-approved vaccines and treatments means current care focuses on supportive measures, highlighting the importance of developing vaccines to control outbreaks, especially as OROV risk increases with climate change and global travel.
View Article and Find Full Text PDF

Integrated surveillance for Oropouche Virus: Molecular evidence of potential urban vectors during an outbreak in the Brazilian Amazon.

Acta Trop

December 2024

Fiocruz Rondônia - Fundação Oswaldo Cruz, Laboratório de Entomologia, Porto Velho, Rondônia, Brazil; Programa de Pós-Graduação em Biologia Experimental - PGBIOEXP, Fundação Universidade Federal de Rondônia/ Fiocruz Rondônia, Porto Velho, Rondônia, Brazil; INCT-EpiAmO Instituto Nacional de Epidemiologia da Amazônia Ocidental, Porto Velho, Rondônia, Brazil.

The Oropouche Virus (OROV) has Culicoides paraensis as its main vector in the urban cycle. Diagnoses of acute febrile cases and entomological collections were performed between January and April 2024 in the urban setting of Porto Velho, a city located in the western Brazilian Amazon. A total of 904 human samples were evaluated using RT-qPCR, of which 328 were positive for OROV.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!